• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA作为心脏发育和心血管疾病的关键调节因子

Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.

作者信息

Kawaguchi Satoshi, Moukette Bruno, Hayasaka Taiki, Haskell Angela K, Mah Jessica, Sepúlveda Marisa N, Tang Yaoliang, Kim Il-Man

机构信息

Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

出版信息

J Cardiovasc Dev Dis. 2023 Apr 12;10(4):166. doi: 10.3390/jcdd10040166.

DOI:10.3390/jcdd10040166
PMID:37103045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10143661/
Abstract

Noncoding RNAs (ncRNAs) play fundamental roles in cardiac development and cardiovascular diseases (CVDs), which are a major cause of morbidity and mortality. With advances in RNA sequencing technology, the focus of recent research has transitioned from studies of specific candidates to whole transcriptome analyses. Thanks to these types of studies, new ncRNAs have been identified for their implication in cardiac development and CVDs. In this review, we briefly describe the classification of ncRNAs into microRNAs, long ncRNAs, and circular RNAs. We then discuss their critical roles in cardiac development and CVDs by citing the most up-to-date research articles. More specifically, we summarize the roles of ncRNAs in the formation of the heart tube and cardiac morphogenesis, cardiac mesoderm specification, and embryonic cardiomyocytes and cardiac progenitor cells. We also highlight ncRNAs that have recently emerged as key regulators in CVDs by focusing on six of them. We believe that this review concisely addresses perhaps not all but certainly the major aspects of current progress in ncRNA research in cardiac development and CVDs. Thus, this review would be beneficial for readers to obtain a recent picture of key ncRNAs and their mechanisms of action in cardiac development and CVDs.

摘要

非编码RNA(ncRNAs)在心脏发育和心血管疾病(CVDs)中发挥着重要作用,而心血管疾病是发病和死亡的主要原因。随着RNA测序技术的进步,近期研究的重点已从特定候选物的研究转向全转录组分析。得益于这类研究,已鉴定出一些新的ncRNAs,它们与心脏发育和心血管疾病有关。在本综述中,我们简要描述了ncRNAs分为微小RNA、长链非编码RNA和环状RNA的分类情况。然后,我们通过引用最新的研究文章来讨论它们在心脏发育和心血管疾病中的关键作用。更具体地说,我们总结了ncRNAs在心脏管形成和心脏形态发生、心脏中胚层特化以及胚胎心肌细胞和心脏祖细胞中的作用。我们还重点介绍了最近在心血管疾病中作为关键调节因子出现的六种ncRNAs。我们相信,本综述简要阐述了ncRNA在心脏发育和心血管疾病研究中当前进展的也许并非全部但肯定是主要方面。因此,本综述将有助于读者了解关键ncRNAs及其在心脏发育和心血管疾病中的作用机制的最新情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/6d65c36e55f2/jcdd-10-00166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/bd71a436c851/jcdd-10-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/7fdca20e3cba/jcdd-10-00166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/6d65c36e55f2/jcdd-10-00166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/bd71a436c851/jcdd-10-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/7fdca20e3cba/jcdd-10-00166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f5/10143661/6d65c36e55f2/jcdd-10-00166-g003.jpg

相似文献

1
Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.非编码RNA作为心脏发育和心血管疾病的关键调节因子
J Cardiovasc Dev Dis. 2023 Apr 12;10(4):166. doi: 10.3390/jcdd10040166.
2
Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.microRNAs、长链非编码 RNAs 和环状 RNAs 在心血管疾病中的临床意义。
Cells. 2023 Jun 14;12(12):1629. doi: 10.3390/cells12121629.
3
Interactions between noncoding RNAs as epigenetic regulatory mechanisms in cardiovascular diseases.非编码 RNA 作为心血管疾病表观遗传调控机制的相互作用。
Methods Cell Biol. 2021;166:309-348. doi: 10.1016/bs.mcb.2021.06.002. Epub 2021 Jul 17.
4
Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.系统评价非编码 RNA 在心血管疾病中的调控原则。
Brief Bioinform. 2019 Jan 18;20(1):66-76. doi: 10.1093/bib/bbx095.
5
Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.环状非编码 RNA 作为心血管疾病的潜在治疗方法和循环生物标志物。
Acta Pharmacol Sin. 2018 Jul;39(7):1100-1109. doi: 10.1038/aps.2017.196. Epub 2018 Mar 22.
6
Noncoding RNAs in age-related cardiovascular diseases.非编码 RNA 与年龄相关性心血管疾病。
Ageing Res Rev. 2022 May;77:101610. doi: 10.1016/j.arr.2022.101610. Epub 2022 Mar 23.
7
Extracellular Non-Coding RNAs in Cardiovascular Diseases.心血管疾病中的细胞外非编码RNA
Pharmaceutics. 2023 Jan 3;15(1):155. doi: 10.3390/pharmaceutics15010155.
8
Autophagy in cardiovascular diseases: role of noncoding RNAs.心血管疾病中的自噬:非编码RNA的作用
Mol Ther Nucleic Acids. 2020 Nov 4;23:101-118. doi: 10.1016/j.omtn.2020.10.039. eCollection 2021 Mar 5.
9
ncRNAs and polyphenols: new therapeutic strategies for hypertension.ncRNAs 和多酚:高血压的新治疗策略。
RNA Biol. 2022;19(1):575-587. doi: 10.1080/15476286.2022.2066335. Epub 2021 Dec 31.
10
Regulation of pyroptosis in cardiovascular pathologies: Role of noncoding RNAs.心血管疾病中细胞焦亡的调控:非编码RNA的作用
Mol Ther Nucleic Acids. 2021 May 29;25:220-236. doi: 10.1016/j.omtn.2021.05.016. eCollection 2021 Sep 3.

引用本文的文献

1
Cellular Models of Aging and Senescence.衰老与细胞衰老的细胞模型
Cells. 2025 Aug 18;14(16):1278. doi: 10.3390/cells14161278.
2
Transformative Potential of Induced Pluripotent Stem Cells in Congenital Heart Disease Research and Treatment.诱导多能干细胞在先天性心脏病研究与治疗中的变革潜力。
Children (Basel). 2025 May 23;12(6):669. doi: 10.3390/children12060669.
3
Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension.

本文引用的文献

1
Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).勘误:《2022 ESC/ERS肺动脉高压诊断和治疗指南》:由欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗特别工作组制定。得到国际心肺移植学会(ISHLT)和欧洲罕见呼吸系统疾病参考网络(ERN-LUNG)认可。
Eur Heart J. 2023 Apr 17;44(15):1312. doi: 10.1093/eurheartj/ehad005.
2
The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1.长链非编码 RNA THBS1-AS1 通过调节 TGFBR1 促进心脏成纤维细胞激活在心脏纤维化。
JCI Insight. 2023 Mar 22;8(6):e160745. doi: 10.1172/jci.insight.160745.
转化生长因子-β相关信号通路在肺动脉高压中的作用机制、潜在治疗靶点及其下游微小RNA表达
Front Pharmacol. 2025 Jun 6;16:1596767. doi: 10.3389/fphar.2025.1596767. eCollection 2025.
4
RNA Structure: Past, Future, and Gene Therapy Applications.RNA结构:过去、未来及基因治疗应用
Int J Mol Sci. 2024 Dec 26;26(1):110. doi: 10.3390/ijms26010110.
5
miRNAs in the diagnosis and therapy of cardiac and mediastinal tumors: a new dawn for cardio-oncology?微小RNA在心脏和纵隔肿瘤诊断与治疗中的应用:心脏肿瘤学的新曙光?
Future Cardiol. 2024;20(14):795-806. doi: 10.1080/14796678.2024.2419225. Epub 2024 Nov 8.
6
Global genomic profile of hippocampal endothelial cells by single-nuclei RNA sequencing in female diabetic mice is associated with cognitive dysfunction.对雌性糖尿病小鼠海马内皮细胞进行单细胞 RNA 测序的全基因组图谱与认知功能障碍有关。
Am J Physiol Heart Circ Physiol. 2024 Oct 1;327(4):H908-H926. doi: 10.1152/ajpheart.00251.2024. Epub 2024 Aug 16.
7
Crosstalk of ubiquitin system and non-coding RNA in fibrosis.泛素系统与非编码RNA在纤维化中的相互作用
Int J Biol Sci. 2024 Jul 8;20(10):3802-3822. doi: 10.7150/ijbs.93644. eCollection 2024.
8
Epigenetic Regulation of Mammalian Cardiomyocyte Development.哺乳动物心肌细胞发育的表观遗传调控
Epigenomes. 2024 Jun 29;8(3):25. doi: 10.3390/epigenomes8030025.
9
Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update.非编码 RNA 与肠道微生物群在心律失常发病机制中的作用:最新研究进展。
Genes (Basel). 2023 Aug 30;14(9):1736. doi: 10.3390/genes14091736.
10
Non-Coding RNAs in Human Health and Diseases.非编码 RNA 在人类健康与疾病中的作用
Genes (Basel). 2023 Jul 11;14(7):1429. doi: 10.3390/genes14071429.
3
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
4
Long non-coding RNA lincRNA-erythroid prosurvival attenuates inflammation by enhancing myosin heavy chain 6 stability through recruitment of heterogeneous nuclear ribonucleoprotein L in myocardial infarction.长非编码 RNA lincRNA-erythroid prosurvival 通过募集异质核核糖核蛋白 L 增强肌球蛋白重链 6 的稳定性,从而减轻心肌梗死后的炎症反应。
Bioengineered. 2022 Jun;13(6):14426-14437. doi: 10.1080/21655979.2022.2086376.
5
lncRNA LOC100911717-targeting GAP43-mediated sympathetic remodeling after myocardial infarction in rats.长链非编码RNA LOC100911717靶向GAP43介导大鼠心肌梗死后的交感神经重塑
Front Cardiovasc Med. 2023 Jan 6;9:1019435. doi: 10.3389/fcvm.2022.1019435. eCollection 2022.
6
PVECs-Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR-induced Pulmonary Hypertension.PVECs 衍生的外泌体 microRNAs 通过 FoxM1 信号通路调节 IUGR 诱导的肺动脉高压中的 PASMCs。
J Am Heart Assoc. 2022 Dec 20;11(24):e027177. doi: 10.1161/JAHA.122.027177. Epub 2022 Dec 19.
7
Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.COPD 相关肺动脉高压中肺血管重构及 MicroRNA-126 靶基因的特征。
Respir Res. 2022 Dec 15;23(1):349. doi: 10.1186/s12931-022-02267-4.
8
How vascular smooth muscle cell phenotype switching contributes to vascular disease.血管平滑肌细胞表型转化如何促进血管疾病。
Cell Commun Signal. 2022 Nov 21;20(1):180. doi: 10.1186/s12964-022-00993-2.
9
CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis.环状 GSAP 通过调控 miR-27a-3p/BMPR2 轴缓解肺动脉高压肺微血管内皮细胞功能障碍。
Respir Res. 2022 Nov 19;23(1):322. doi: 10.1186/s12931-022-02248-7.
10
LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.长链非编码 RNA Airn 通过 m6A-IMP2-p53 轴抑制心肌成纤维细胞的激活,从而减轻糖尿病性心脏纤维化。
Biol Direct. 2022 Nov 16;17(1):32. doi: 10.1186/s13062-022-00346-6.